Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hyperfine Inc (HYPR)

Hyperfine Inc (HYPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 61,949
  • Shares Outstanding, K 71,950
  • Annual Sales, $ 11,030 K
  • Annual Income, $ -44,240 K
  • 60-Month Beta 0.82
  • Price/Sales 5.93
  • Price/Cash Flow N/A
  • Price/Book 0.86
Trade HYPR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.59
  • Most Recent Earnings $-0.14 on 05/13/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 239.73% ( -32.30%)
  • Historical Volatility 62.45%
  • IV Percentile 58%
  • IV Rank 19.59%
  • IV High 981.62% on 04/16/24
  • IV Low 58.93% on 08/16/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 391
  • Open Int (30-Day) 500

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.13
  • Low Estimate -0.14
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +6.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7613 +15.46%
on 05/14/24
1.0299 -14.65%
on 05/22/24
+0.0690 (+8.52%)
since 04/24/24
3-Month
0.7613 +15.46%
on 05/14/24
1.3900 -36.76%
on 02/29/24
-0.1510 (-14.66%)
since 02/23/24
52-Week
0.7613 +15.46%
on 05/14/24
3.2800 -73.20%
on 07/18/23
-0.5810 (-39.79%)
since 05/24/23

Most Recent Stories

More News
AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates

AxoGen (AXGN) delivered earnings and revenue surprises of 33.33% and 2.41%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AXGN : 6.27 (+2.62%)
HYPR : 0.8790 (+2.09%)
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates

Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 88.89% and 8.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

TCMD : 12.86 (+0.63%)
HYPR : 0.8790 (+2.09%)
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Lags Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) delivered earnings and revenue surprises of -12.50% and 1.29%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

TNDM : 51.73 (+4.13%)
HYPR : 0.8790 (+2.09%)
Take the Zacks Approach to Beat the Market: Microsoft, Novo Nordisk, General Mills in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

MSFT : 430.16 (+0.74%)
NVO : 136.04 (+0.35%)
HSY : 197.00 (-2.01%)
GIS : 68.30 (-1.14%)
CHD : 106.47 (+0.05%)
LULU : 303.01 (+1.09%)
ROL : 46.19 (+1.78%)
NOBL : 97.99 (+0.30%)
VIST : 44.32 (-2.10%)
PNTG : 23.49 (+3.66%)
HYPR : 0.8790 (+2.09%)
Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day

Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day.

CAR : 111.91 (+1.87%)
VMC : 259.25 (+0.79%)
OMER : 3.35 (+1.82%)
LNTH : 78.22 (-0.99%)
HYPR : 0.8790 (+2.09%)
3 Medical Stocks Creating Wealth Despite Macro Challenges

Here we discuss three stocks - LNTH, OMER and HYPR - that have been creating wealth for their investors in 2023 even though several competitors faltered amid macro challenges. Will the trend continue?

OMER : 3.35 (+1.82%)
LNTH : 78.22 (-0.99%)
HYPR : 0.8790 (+2.09%)
Pre-Market Brief: Stocks Climb on Hopes of Fed Pivot

December S&P 500 futures (ESZ22) are trending higher +1.42% this morning, following a strong rally among three major US benchmark indices during the regular session as weaker than anticipated ISM manufacturing...

ESZ22 : 3,871.47s (-0.66%)
RIVN : 10.44 (+4.92%)
AERC : 3.40 (+0.59%)
XOS : 7.49 (-5.55%)
BFLY : 1.0100 (-1.94%)
AXTI : 3.46 (+7.12%)
HYPR : 0.8790 (+2.09%)
Hyperfine Reports Second Quarter 2022 Financial Results

GUILFORD, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI...

HYPR : 0.8790 (+2.09%)
Viz.ai Partners with Hyperfine to Enable New MR Imaging and Workflow Paradigm

Viz.ai , the leading AI-powered disease detection and intelligent care coordination platform , announced today it is partnering with Hyperfine, Inc. (Nasdaq: HYPR), creator of the first FDA-cleared...

HYPR : 0.8790 (+2.09%)
Hyperfine to Announce Second Quarter 2022 Financial Results on August 10, 2022

GUILFORD, Conn., July 20, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop®, the world's first FDA-cleared portable MRI...

HYPR : 0.8790 (+2.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 0.9523
2nd Resistance Point 0.9261
1st Resistance Point 0.9025
Last Price 0.8790
1st Support Level 0.8527
2nd Support Level 0.8265
3rd Support Level 0.8029

See More

52-Week High 3.2800
Fibonacci 61.8% 2.3179
Fibonacci 50% 2.0206
Fibonacci 38.2% 1.7234
Last Price 0.8790
52-Week Low 0.7613

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar